The metabotropic glutamate receptors (mGluRs) have many important roles in regulation of neuronal excitability and synaptic transmission.
In hippocampal area CAl, activation of mGluRs can reduce both excitatory and inhibitory synaptic transmission.
The conventional view is that the presynaptic effects are mediated by L-Bamino-Cphosphonobutyric acid (L-AP4)-sensitive, or group Ill mGluRs (mGluF14, mGluR6, mGluR7, mGluR8). However, some studies suggest that other mGluR subtypes may also be involved in regulation of excitatory and inhibitory synaptic transmission in area CAl. We have found that two pharmacologically distinct presynaptic receptors are involved in the depression of excitatory transmission at the Schaffer collateral-CA1 synapse. Consistent with previous studies, one receptor subtype is an L-APCsensitive receptor that is pharmacologically similar to mGluR4 or mGluR7. However, we have found that a second mGluR subtype, which is pharmacologically similar to mGluR1 and mGluR5 (group I mGluRs), can also reduce excitatory synaptic transmission in area CAl. Analysis of effects of agonists of these two receptors on miniature EPSCs and paired-pulse facilitation suggest that both receptors are localized presynaptically. It is also shown that the mGluR that reduces transmission at inhibitory synapses in area CA1 is presynaptically localized, is insensitive to L-AP4, and is sensitive to agonists selective for mGluR1 and mGluR5.
[Key words: metabotropic glutamate receptor, presynaptic, synaptic transmission, excitatory amino acid, GABA, ACPD, MCPG, MAP4, MCCG, DHPG] The metabotropic glutamate receptors (mGluRs) comprise a large family of receptors coupled to second messenger systems via GTP-binding proteins. At least eight mGluR subtypes have been cloned to date, and these receptors can be placed into three major groups based on their pharmacology, second-messenger coupling, and sequence homology (see Pin and Duvoisin, 1995, for review) . Group I mGluRs (mGluR1 and mGluR5) couple primarily to phosphoinositide hydrolysis in expression systems, and are potently activated by quisqualate and selectively activated by 3,5-dihydroxyphenylglycine (DHPG; Gereau and Conn, 1995) . The group II mGluRs (mGluR2 and mGluR3) couple to inhibition of adenylyl cyclase in expression systems, and are potently and selectively activated by (2S,l'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine (DCG-IV, Hayashi et al., 1993) . The group III mGluRs (mGluR4, mGluR6, mGluR7, and mGluR8) also couple to inhibition of adenylyl cyclase in expression systems, and are most potently activated by L-AP4 and L-SOP (see Suzdak et al., 1994; Pin and Duvoisin, 1994 , for reviews).
In the hippocampus, activation of mGluRs has a variety of physiological effects. These include a number of direct excitatory effects on CA1 pyramidal cells (Stratton et al., 1989; Desai and Conn, 1991; Liu et al., 1993) and different classes if inhibitory interneurons (Miles and Poncer, 1993; Desai et al., 1994; McBain et al., 1994) . In addition, mGluR activation reduces both excitatory (Baskys and Malenka, 1991; Pacelli and Kelso, 1991; Desai et al., 1992 Desai et al., , 1994 and inhibitory (Desai and Conn, 1991; Pacelli and Kelso, 1991; Desai et al., 1992 Desai et al., , 1994 Liu et al., 1993) synaptic transmission in the hippocampus (see Glaum and Miller, 1994, for review) . The conventional view has been that the depression of excitatory transmission is mediated by a group III mGluR, because mGluR autoreceptors are often sensitive to the selective group III agonist, L-AP4 (Evans et al., 1982; Lanthorn et al., 1984; Cotman et al., 1986; Baskys and Malenka, 1991) . However, several studies suggest that other mGluR subtypes may also be involved. First, while L-AP4 reduces transmission at the Schaffer collateral-CA1 synapse, this effect is mimicked by quisqualate at concentrations that are inactive at the group III mGluRs (Baskys and Malenka, 1991) . In addition, the depression of transmission at this synapse by lS,3R-l-aminocyclopentane-1,3-dicarboxylic acid (1 S,3R-ACPD) is antagonized by (R,S)-a-methyl-4-carboxyphenylglycine (MCPG) (Watkins and Collingridge, 1994 ; but see also Chinestra et al., 1993) . Because MCPG is an antagonist at mGluR1 and mGluR2, but not mGluR4 or mGluR7 (Hayashi et al., 1994; Saugstad et al., 1994) these data suggest that a receptor other than a group IlI mGluR may be involved in modulation of transmission at the Schaffer collateral-CA1 synapse. Thus, the nature of the mGluR subtype or subtypes that mediate depression of excitatory synaptic transmission are not entirely clear Previous studies have shown that activation of mGluRs also reduces transmission at GABAergic synapses onto CA1 pyramidal cells (Desai et al., 1994) . However, little pharmacological data is available from which one can glean information regard-ing the mGluR subtypes responsible for the modulation of GABAergic transmission. Furthermore, it is not known if mGluRs act presynaptically or postsynaptically to reduce IPSPs.
We now report that at least two pharmacologically distinct mGluRs are involved in modulation of excitatory synaptic transmission at the Schaffer collateral-CA1 synapse. One receptor has a pharmacology similar to the group I mGluRs, whereas the other receptor has a group III-like pharmacology. Analysis of miniature EPSCs and paired-pulse facilitation suggests that both receptors are presynaptic, but that they decrease glutamate release via different mechanisms. In addition, a group I-like receptor is involved in modulating transmission from GABAergic interneurons onto CA1 pyramidal cells. Analysis of spontaneous miniature IPSCs suggests that the depression of GABA transmission is likely mediated by a receptor that is presynaptically localized.
Materials and Methods
Materials. DCG-IV was generously supplied by Dr. H. Shinozaki (Tokyo Metropolitan Institute for Medical Sciences; Tokyo, Japan). lS,3R-ACPD, lS,3S-ACPD, DHPG, quisqualate, L-2-amino-4-phosphonobutyric acid (L-AP4), (+)MCPG, a-methyl-LAP4 (MAP4), and (2S,3S,4S)-2-methyl-2-(carboxycyclpropyl)glycine (MCCG) were purchased from Tocris Cookson (Bristol, UK). All other drugs were purchased from Sigma (St. Louis, MO).
Hippocampal slice preparation. The hippocampus from 100-180 gm (30-40~d-old) male Sprague-Dawley rats was dissected on ice and 400 pm transverse slices were prepared using a Mcllwain tissue chopper. Slices were placed into oxygenated artificial cerebrospinal fluid (A&F) containing (in mu) NaCl 124, KC1 2.5, CaCl, 2. MESO, 1.3. NaMPO, 1, glucose i0, and NaHCO, 26, equilibrated-to' ~$7.4~with 95%* Ol 5% CO,. After a 1 hr recovery period, a slice was transferred to a submerged brain slice recording chamber, where it was continuously perfused with oxygenated ACSF at 1 ml/min. During the recovery period, slices were generally maintained at room temperature (19-22"(Z) , except for experiments on spontaneous mEPSCs, in which the slices were maintained at approximately 25°C.
Field potential recordings. Field potential recording electrodes were pulled on a Flaming Brown electrode puller (Sutter Instruments, San Rafael, CA) from 1.2 mm borosilicate glass (World Precision lnstruments, Sarasota, FL) to a resistance of l-2 Ma with a filling solution of 2 M NaCl. A bipolar tungsten stimulating electrode was placed in stratum radiatum at approximately the CA3-CA1 border for stimulation (0.1 msec; square wave) of Schaffer collateral afferents to area CAl, and the stimulus intensity was adjusted until field potential responses to afferent stimulation were less than 50% of maximal. Recording electrodes were placed in stratum radiatum of area CAl. Field potential recordings were performed at approximately 25°C using an Axoclamp 2A (Axon Instruments, Foster City, CA) in bridge mode.
Intracellular recordings. For recording inhibitory postsynaptic potentials, sharp microelectrodes were fabricated from 1.2 mm borosilicate glass (WPI) using a Flaming Brown electrode puller. Electrodes were filled with 2 M KMeSO.,, and had resistances from 150-250 Ma. In experiments in which monosynaptically evoked IPSPs were isolated, the stimulating electrode was placed close to the recording site, and the bathing ACSF contained 1 mu kynurenate to block fast glutamatergic transmission. Blockade of excitatory transmission was confirmed by the absence of a depolarizing synaptic potential following afferent stimulation. Stimulus intensity waS adjusted to evoke a response < 50% of maximal. Cells were manually "clamped" at the original resting membrane potential by current injection for the duration of the experiment.
Whole-cell patch clamp recordings. Whole-cell patch clamp recordings were obtained from CA1 pyramidal cells using a Warner lnstruments Corp (Hamden CT) patch clamp model PC-5OlA using the "blind" patch technique as described by Blanton et al. (1989) . Patch clamp recordings were performed at room temperature, except for experiments measuring mEPSCs, for which the temperature was elevated to approximately 25°C. This increase in temperature substantially increased the frequency of spontaneous events. Patch electrodes were fabricated from 1.5 mm borosilicate glass (World Precision Instruments, Sarasota, FL) to a resistance of 2-7 MO with a filling solution that contained (in mu) HEPES 40, Gluconic acid 100, EGTA 0.6, GTP 0.3, ATP 2, MgCl, 5, pH to 7.4 with 50% CsOH for EPSCs. The electrode solution for recording IPSCs was identical except that CsCl was substituted for the gluconic acid. Cells with a series resistance of greater than 25 Ma were discarded, and no series resistance compensation was used. ACSF for EPSC recordings contained 100 PM picrotoxin, and the Schaffer collateral pathway was cut at the CAS/CAl border to reduce the impact of recurrent excitatory circuits on CA1 recordings. Stimuli were delivered to the Schaffer collateral pathway at a rate of l/30 sec. For mEPSC and mlPSC recordings, ACSF contained TTX (500 nM). In mIPSC recordings, fast glutamatergic transmission was blocked by the inclusion of kynurenate (1 mu) in the bathing ACSE Agonists and antagonists were dissolved in ACSF at 10X final concentration and added to the perfusion medium using a Sage syringe pump. All agonist applications used in computation of mean effects were 10 min in duration to allow equilibration with the drug with the tissue. Exceptions include picrotoxin, TTX, and kynurenate, which were diluted to final concentration in the bathing ACSF and applied for the duration of the experiment when used. Kynurenate was dissolved in 1 N NaOH before being diluted to the final concentration in ACSE The pH of the ACSF was then adjusted to 7.4 using 12 N HCl. MCPG, MAP4, MCCG, L-AP4, lS,3S-ACPD, lS,3R-ACPD, and quisqualate were all dissolved at 2 100X final concentration in 0.1 N NaOH before being diluted to 10X final concentration with ACSE Evoked potential and evoked current data were acquired and analyzed using pClamp software (Axon lnsturuments). Miniature EPSC and IPSC data were collected using Axotape software (Axon lnsturments). Data were digitized at 5 KHz and filtered at 0.5-l KHz and written directly to a computer hard drive. mEPSC and mlPSC analysis was carried out using the N spontaneous events analysis software, generously provided by Dr. Stephen Traynelis (Emory University, Department of Pharmacology).
Results
Agonist pharmacology of the depression of synaptic transmission at the Schaffer collateral-CA1 synapse
Previous studies suggest that a group III mGluR may be involved in regulation of excitatory synaptic transmission at the Schaffer collateral-CA1 synapse. However, this hypothesis has not been rigorously tested. Previous studies suggest that 3,5-dihydroxyphenylglycine (DHPG) is a highly selective agonist for the group I mGluRs (mGluR1 and mGluR5; Schoepp et al., 1994; Gereau and Conn, 1995) . We and others have also shown that (2S,l'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine (DCG-IV) is highly selective for the group Il mGluRs (mGluR2 and mGluR3; Hayashi et al.,. 1992; Gereau and Conn, 1995) , and much work suggests that LAP4 has a high degree of selectivity for the group III mGluRs (mGluRs 4, 6, 7, and 8; see Suzdak et al., 1994, for review). We tested the hypothesis that the mGluR autoreceptor at the Schaffer collateral-CA1 synapse belongs to group III by examining the effects of these group-selective agonists on evoked excitatory postsynaptic currents (EPSCs) recorded from CA1 pyramidal cells in response to stimulation of Schaffer collaterals.
In agreement with previous reports, we found that the group IIIselective agonist D,L-AP4 (1 mu) induced a reversible depression of EPSCs in area CA1 (Fig. 1) . However, we also found that the group I-selective agonist, DHPG (100 p,~), induced a depression of EPSCs. The group II-selective agonist, DCG-N; had no effect on the amplitude of evoked EPSCs (Fig. 1) . The finding that both DHPG and L-AP4 inhibit EPSCs suggests that this response could not be mediated solely by a group III mGluR. We also determined the rank order of potency of a variety of mGluR agonists at reducing field excitatory postsynaptic potentials (fEPSPs) in area CAl. The agonist rank order of potency for depression of fEPSPs was DHPG S-lS,3R-ACPD > lS,3S-ACPD 2 LAP4 > L-SOP (Fig. 2) . This rank order of agonist potency differs from that of the group III mGluRs or any of the mGluRs cloned to date (see Pin and Duvoisin, 1994 , for review). These data could be interpreted in one of two ways. First, these data could suggest that both group I and group III mGluRs are involved in regulating transmission at the Schaffer collateral-CA1 synapse. This would be consistent with the effects of DHPG and L-AP4, as well as the rank order of agonist potencies. However, it is also possible that this response is mediated by a single mGluR subytpe that is pharmacologically distinct from any of the mGluRs that have been cloned to date. Thus, we performed a series of studies to differentiate between these two possibilities.
Antagonist profiles suggest that multiple mGluRs modulate excitatory synaptic transmission If the effects of DHPG and L-AP4 are mediated by the same receptor, then the depression of transmission induced by the two agonists should be similarly blocked by an antagonist of the receptor. If, however, the effects of DHPG and L-AP4 are mediated by activation of two distinct receptors, then an antagonist
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[Agonist] (fl) may block the effects of one agonist, but not the other. Therefore, in order to test the hypothesis that the depression of synaptic transmission at the Schaffer collateral-CA1 synapse induced by DHPG is mediated by a receptor other than the L-AP4-sensitive receptor at this synapse, we tested the ability of several mGluR antagonists to block the effects of submaximal concentrations of DHPG and L-AP4 on fEPSPs in area CAl. Previous studies have shown that (+)MCPG is an antagonist of at least two mGluR subtypes: mGluR1 and mGluR2, while it is inactive at mGluR4 and mGluR7 (Hayashi et al., 1994; Saugstad et al., 1994) . Of these receptors, DHPG activates only mGluR1 and mGluR5 (Gereau and Conn, 1995) , whereas L-AP4 activates only the group III mGluRs, of which only mGluR4 and mGluR7 are expressed in the hippocampus (see Testa et al., 1994, for review; Okamoto et al., 1994; Saugstad et al., 1994) . We tested the ability of (+)MCPG (500 FM) to block the depression of fEPSPs induced by submaximal concentrations of DHPG (31.6 p,M) and L-AP4 (3 16-500 FM).
Interestingly, MCPG markedly inhibited DHPG-induced depression of fEPSPs (p < 0.01; N = 4; Fig. 3 ). In contrast, the depression of fEPSPs induced by two different concentrations of L-AP4 was completely unaffected by inclusion of (+)MCPG in the ACSF (p > 0.05, N = 4; Fig. 3 ).
Two novel mGluR antagonists, cl-methyl-CCGl (MCCG) and a-methyl-L-AP4 (MAP4) have recently been described, and these drugs exhibit some selectivity for antagonism of depression of synaptic responses in the spinal cord by trans-ACPD and L-AP4, respectively (Jane et al., 1994) , and reduction of GABAergic transmission in the thalamus by L-CCGl and L-AP4, respectively (Salt and Eaton, 1995) . It is suggested that MCCG is an antagonist for the group II mGluRs because it blocks the effects of L-CCGl, highly potent group II agonist, and that MAP4 is a selective antagonist for group III mGluRs, because it selectively blocks the effects of L-AP4, the most potent agonist at the group III mGluRs (Jane et al., 1994; Salt and Eaton, 1995) . However, the effects of these compounds on the cloned mGluRs are not yet known. At concentrations that completely inhibited the effects of trans-ACPD in spinal cord, MCCG (250 FM) had no effect on the depression of fEPSPs induced by either DHPG (31.6 p.M) or L-AP4 (500 PM). Simi- Time (min) larly, at concentrations that completely blocked the effects of L-AP4 in the spinal cord, MAP4 (500 FM) had no effect on the fEPSP depression induced by DHPG or L-AP4 (Fig. 3) .
Distinct presynaptic loci for inhibition of excitatory synaptic transmission Previous studies suggest that the nonselective mGluR agonist trans-ACPD may reduce excitatory synaptic transmission at the Schaffer collateral-CA1 synapse by a presynaptic mechanism, because trans-ACPD has no effect on AMPA-evoked currents in CA1 pyramidal cells, but alters paired-pulse facilitation at this synapse (Baskys and Malenka, 1991) . However, the locus of the L-AP4 and DHPG-induced depression of excitatory synaptic transmission is unknown. In order to determine whether L-AP4 and DHPG reduce transmission at the Schaffer collateral-CA1 synapse by presynaptic mechanisms, the effects of maximal concentrations of these drugs on frequency and amplitude of spontaneous miniature EPSCs (mEPSCs) was determined. Whole-cell recordings were made from CA1 pyramidal cells in the presence of TTX (500 DM) to block action potential-dependent release events, and picrotoxin (100 FM) to block GA-BAA-mediated synaptic currents. All remaining synaptic currents were completely blocked by inclusion of the ionotropic glutamate receptor antagonist, kynurenate (1 mu; see Fig. 5A ). L-AP4 (1 mM) significantly reduced the frequency of mEPSCs in area.CAl, but had no effect on the amplitude distribution of mEPSCs, suggesting that L-AP4 acts presynaptically to reduce glutamate release ( Fig. 4; Table 1 ). DHPG (100 FM) did not significantly reduce mEPSC frequency or amplitude, suggesting that DHPG also acts presynaptically to reduce transmission, but likely through a different mechanism than the L-AP4-sensitive receptor ( Fig. 5; Table 1 ). Neither L-AP4 nor DHPG significantly altered the rise time or decay kinetics of mEPSCs ( Table  1 ), suggesting that these agonists did not significantly alter space 
clamp. Although we did not detect any change in mEPSC amplitude in response to L-AP4 or DHPG, manipulations that alter postsynaptic responses did result in discernable effects on mEPSC amplitude. Thus, by changing the holding potential from -90 to -40 mV, we were able to detect large shifts in the amplitude distribution of mEPSCs, while the frequency was unaffected (N = 3; Fig. 4F,G) . Similar results were observed in response to low doses of the selective nonNMDA ionotropic glutamate receptor antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX; 1 pM, not shown). The finding that manipulations known to alter EPSCs by a postsynaptic mechanism reduce mEPSC amplitude but not frequency suggests that our methods are sensitive to postsynaptic changes. Therefore, the lack of effect of the mGluR agonists on mEPSC amplitude are consistent with a presynaptic site of action of L-AP4 and DHPG, rather than a postsynaptic antagonism. The finding that L-AP4 has no postsynaptic antagonist action is consistent with previous findings that L-AP4 at concentrations up to 1 mM does not block depolarizations induced by exogenously applied glutamatergic agonists (Evans et al., 1982) . Another method that is often used to determine whether a compound reduces synaptic transmission by a presynaptic or postsynaptic mechanism is measurement of paired-pulse facilitation. Agents that act presynaptically to reduce transmission generally potentiate paired-pulse facilitation, whereas agents that act postsynaptically induce a proportional decrease in the first and second responses in a paired-pulse facilitation protocol and therefore have no effect on paired-pulse facilitation. In agreement with the results of the mEPSC experiments, we found that both L-AP4 (1 mu; N = 3) and DHPG (100 pM; N = 3) altered paired-pulse facilitation at this synapse, consistent with a presynaptic site of action. In contrast, DNQX, (1 FM) reduced the first and second fEPSPs proportionally, consistent with its known postsynaptic site of action (Fig. 6) . . L-AP4 reduces the frequency but not the amplitude of spontaneous miniature EPSCs. mEPSCs were recorded from CA1 pyramidal cells in the presence of TTX (500 nM) and picrotoxin (100 PM). A, Continuous records taken immediately prior to addition of L-AP4 (predrug) and after 10 min in L-AP4 (1 mu). Traces are 1.5 set in duration and are separated by 40 pA. B and C, Amplitude histograms of mEPSCs recorded for 2 min before drug addition (B) and after 10 min in the presence of L-AP4 (1 mu, C). All events were measured and sorted into 1 pA bins. D, Cumulative frequency plot demonstrating the lack of effect of L-AP4 on mEPSC amplitude (Kolmogorov-Smirnov test; p > 0.01). E, Cumulative probability plot demonstrating the significant effect of L-AP4 on interevent interval (Kolmogorov-Smirnov test, p < 0.0001). Similar results were observed in three separate experiments. F, Control experiment demonstrating that a change in postsynaptic EPSC driving force results in a detectable change in mEPSC amplitude (Kolmogorov-Smirnov test, p < 0.0001). G, Overlayed average EPSCs of all events showing the effect of a change in holding potential on mEPSC amplitude and the lack of effect of L-AP4 on mEPSC amplitude.
The effects on mEPSCs and paired-pulse facilitation are con-(Lester and Jahr, 1990; Swartz and Bean, 1992; Trombley and sistent with presynaptic sites of action for L-AP4 and DHPG.
Westbrook, 1992; Sahara and Westbrook, 1993; Swartz et al., L-AP4 appears to be acting, at least in part, by decreasing the 1993; Stefani et al., 1994) . Since presynaptic calcium channels release probability. However, since DHPG has no effect on eiare voltage dependent and mEPSCs are not dependent on action ther frequency or amplitude of mEPSCs, the mechanism of acpotential firing, it is possible that agonists that decrease synaptic tion of DHPG is less clear. Several studies have shown that transmission by inhibitiing calcium channel conductance would mGluR activation can inhibit voltage-sensitive calcium channels not decrease mEPSC frequency. We tested this possibility under Figure 5 . DHPG has no effect on frequency or amplitude of spontaneous miniature EPSCs. mEPSCs were recorded from CA1 pyramidal cells in the presence of TTX (500 nM) and picrotoxin (100 FM). A, Continuous records taken immediately prior to addition of DHPG (predrug), after 10 min in DHPG (100 FM), and in the presence of kynurenate (1 mM). Traces are 1.5 set in duration and are separated by 40 pA. B and C, mEPSC amplitude histograms. mEPSCs were recorded for 1 min prior to drug addition (B) and after 10 min in DHPG (C). All events were measured and sorted into 1 pA bins. Number of events in the 60 set prior to DHPG addition = 90, number of events in 60 set after 10 min in DHPG = 91. D, Overlayed averages of all mEPSCs recorded during the time periods shown in B and C demonstrating the lack of effect of DHPG on mEPSC amplitude and kinetics. E, Cumulative probability plot demonstrating the lack of effect of DHPG on mEPSC amplitude (Kolmogorov-Smirnov test; p > 0.01). F, Cumulative probability plot showng the lack of effect of DHPG on interevent interval (Kolmogorov-Smirnov test; p > 0.01). Similar results were observed in three separate experiments.
the conditions used for measurement of the effect of DHPG on mEPSCs by determining the effect of the calcium channel blocker cadmium on mEPSCs and evoked fEPSPs. Consistent with a previous report (Parfitt and Madison, 1993) , we found that 1 mu CdCl, completely blocked evoked fEPSPs but had no effect on the frequency or amplitude of mEPSCs (Fig. 7) .
A group I mGluR modulates GABAergic transmission in area CA1 Previous studies have shown that lS,3R-ACPD can reduce GABA-mediated IPSPs in area CA1 (Desai and Conn, 1991; Pacelli and Kelso, 1991; Desai et al., 1992 Desai et al., , 1994 Liu et al., 1993) . This is mediated by a combination of reducing transmission at excitatory synapses onto interneurons and inhibitory synapses onto pyramidal cells (Desai et al., 1994) . While it is clear from these studies that mGluR activation inhibits transmission at GABAergic synapses, the pharmacology of the receptor mediating this response, as well as its site of action, are unknown.
In order to determine if multiple mGluRs could also regulate GABAergic transmission in area CAl, the effects of the groupselective agonists DHPG, DCG-IV, and L-AP4 on monosynaptically evoked IPSPs were determined.
As was the case for excitatory transmission, the group I-selective agonist, DHPG (100 PM) was found to reduce monosynaptic IPSPs in area CA1 (Fig. 8) . However, both the group IIselective agonist, DCG-IV (1 PM), and the group III-selective agonist, L-AP4 (1 mu), were without effect on monosynaptic IPSP amplitude. This finding suggests that transmission at GABAergic synapses in area CA1 is regulated by a group I-like mGluR. Consistent with this, we found that quisqualate (10 FM), another potent and relatively selective group I mGluR agonist, also reduced the amplitude of monosynaptic IPSPs in area CA1 (Fig. 8) . As was the case for modulation of excitatory synaptic transmission, the depression of monosynaptic IPSPs induced by DHPG (100 pM) was completely inhibited by inclusion of 500 FM (+)MCPG in the bathing ACSF (Fig. 9) . DHPG on the frequency and amplitude of spontaneous miniature IPSCs (mIPSCs) to differentiate between these possible mechanisms. If mGluRs act postsynaptically to reduce the effects of GABA, then one would expect to observe a decrease in the mean amplitude of mIPSCs. In contrast, if the reduction in IPSPs is mediated by a decrease in the number of quanta of GABA released, then no effect on mIPSC amplitude would be observed. mIPSCs were recorded using whole-cell recordings from chloride-loaded CA1 pyramidal cells in the presence of TTX (500 nM) and kynurenate (1 mu). Under these conditions, mIPSCs are inward currents when the cell is voltage clamped at -70 mV. All spontaneous synaptic events recorded under these conditions were blocked by addition of the GABA, receptor antagonist, bicuculline (100 FM; see Fig. 10 ). DHPG (100 FM) had no significant effect on either the amplitude or the frequency of mIPSCs, consistent with a presynaptic site of action (Fig. 10) . The mean (t SEM) amplitude of mIPSCs recorded in the presence of DHPG was 102.4 ? 8.7% of the predrug amplitude, and the frequency of mIPSCs was 99.8 2 10.8% of predrug values (N = 3). As mentioned above, mGluR activation reduces the amplitude of polysynaptic IPSPs by reducing excitatory synaptic transmission onto CA1 interneurons and by inhibiting GABAmediated transmission onto CA1 pyramidal cells (Desai et al., 1994) . Thus, although L-AP4 does not reduce transmission at GABAergic synapses (as indicated by the lack of effect on monosynaptic IPSPs), it is possible that group III mGluRs could be involved in the reduction of polysynaptic IPSPs by virtue of their effects on excitatory synaptic transmission. We tested this hypothesis by determining the effect of the group-selective mGluR agonists on polysynaptic IPSPs in area CAl. Interestingly, while only DHPG was effective at reducing monosynaptic IPSPs, both DHPG (100 FM) and L-AP4 (1 mM) reduced the amplitude of polysynaptically evoked IPSPs in area CA1 (Fig.  11) . The group II-selective agonist, DCG-IV (1 FM), had no effect on polysynaptic IPSPs.
Discussion
The data presented here suggest that two distinct mGluR subtypes can serve as presynaptic autoreceptors involved in reducing glutamate release from Schaffer collateral terminals in area CA1 of the hippocampus. DHPG, a highly selective agonist for group I mGluRs, and L-AP4, a selective group III mGluR ag-(I I IO IS 20 25 I" rnEPSC Amplitude (PA) Figure   7 . Blockade of voltage-sensitive calcium channels does not alter mEPSC frequency or amplitude. A,B, Continuous records recorded immediately prior to (A) and after 6 min in the presence of 1 mu CdCl, (B) . Records are 1.5 set in duration and are separated by 40 pA. C, Cumulative frequency plot demonstrating the lack of effect of CdCl, on mEPSC amplitude. D, Representative fEPSPs recorded immediately prior to addition of CdCl, (control), after approximately 2 min in 1 mu CdCl,, and after an extensive wash period. E, Mean (2 SEM) data from three experiments in each group showing the lack of effect of CdCl, on mEPSC frequency and amplitude, and the complete blockade of evoked fEPSPs by CdCl,. B, Mean + SEM of five to seven experiments in each group showing the significant depression of monosynaptic IPSPs by the group I agonists DHPG (100 FM) and quisqualate (10 PM) and the lack of effect of DCG-IV (1 PM) and D,L-AP4 (1 mM). *p < 0.05, ANOVA. The group labeled AP4 includes four experiments using 1 mu D,L-AP4 and two experiments using 1 mu L-AP4. onist, both reduce transmission at the Schaffer collateral-CA1 synapse. Furthermore, depression of fEPSPs by DHPG was blocked by the mGluR l/2 antagonist, (+)MCPG, whereas the depression of fEPSPs by L-AP4 was insensitive to (+)MCPG, suggesting that the responses to these two agonists are mediated by distinct mGluR subtypes. Finally, biophysical studies suggest that the effects of these two agonists are mediated by different mechanisms. Thus, L-AP4 induced a significant depression of mEPSC frequency, whereas DHPG had no effect on mEPSC frequency.
The present finding that L-AP4 can completely inhibit transmission at the Schaffer collateral-CA1 synapse in 30-40-d-old rats seems to be in contrast to the studies of Baskys and Malenka (1991) , which show that the inhibition of transmission at this synapse by L-AP4 is developmentally downregulated and is virtually absent in rats aged over 30 d. However, these studies only examined the effects of a single concentration (50 FM) of L-AP4. Thus, the findings presented here may reflect a developmental decrease in the potency of L-AP4. there is a developmental decrease in the receptor reserve, which would result in a decrease in the agonist potency. It is also possible that the predominant group III mGluR expressed in adult rats is different from that expressed in younger animals. For example, of the group III mGluRs expressed in rat hippocampus, L-AP4 activates mGluR4 much more potently than mGluR7 (see Suzdak et al., 1994 , for review). Thus, it is possible that mGluR4 is more strongly expressed in Schaffer collateral terminals of younger animals, whereas mGluR7 is the predominant receptor in older rats. Future studies using quantitative immunoblotting should address this possibility. Previous studies have demonstrated that L-AP4 also potently reduces transmission at mossy fiber-CA3 synapses in the guinea pig, but not the rat (Lanthorn et al., 1984) . Our finding that L-AP4 decreases mEPSC frequency is in contrast to the effects of L-AP4 at mossy fiber-CA3 synapses in guinea pig, where L-AP4 reduces evoked EPSPs, but has no effect in the amplitude or frequency of miniature EPSPs (Cotman et al., 1986) . Thus, it is likely that L-AP4-sensitive receptors decrease transmission at this synapse through a different mechanism than those at the rat Schaffer collateral-CA1 synapse.
As discussed above, DHPG is a highly selective agonist for the group I mGluRs (Ito et al., 1992; Schoepp et al., 1994; Gereau and Conn, 1995) . Taken together with previous studies showing that quisqualate also reduces excitatory synaptic transmission at this synapse (Baskys and Malenka, 1991) , these data suggest that a group I mGluR (mGluR1 or mGluR5) or a closely -., -related receptor is likely to be involved in regulation of excitatory synaptic transmission at the Schaffer collateral-CA1 synapse. At present, it is not known which group I mGluR may be localized on Schaffer collateral terminals. Previous studies have shown that mGluRla does not appear to be localized on excitatory or inhibitory nerve terminals in the hippocampus (Martin et al., 1992; Baude et al., 1993) . However, the subcellular distribution patterns for the other mGluR1 splice variants (mGluRlb/mGluRlc)
are not yet known. Furthermore, the subcellular distribution pattern of mGluR5 has not yet been described. Thus, it is also possible that mGluRlb, mGluRlc, mGluR5, or an as of yet uncloned group I mGluR mediates this depression of EPSCs.
The finding that a group I mGluR can serve as a presynaptic autoreceptor is somewhat surprising since previous studies have suggested that group II and group III mGluRs are the predominant presynaptic mGluRs. However, a number of previous studies are consistent with the finding that group I mGluRs may also have a presynaptic role. For instance, previous studies have shown that mGluR activation decreases high voltage-activated calcium currents in a variety of neurons (Lester and Jahr, 1990; Swartz and Bean, 1992; Sahara and Westbrook, 1993; The Journal of Neuroscience, October 1995, 75(10) al., 1993; Trombley and Westbrook, 1993; Stefani et al., 1994) , and this has been suggested as a mechanism for mGluR-induced reduction of synaptic transmission. Interestingly, it has been shown that approximately 90% of hippocampal pyramidal cells in culture express lS,3R-ACPD-induced inhibition of voltagesensitive calcium channels, whereas only about 10% of the pyramidal cells showed L-AP4-induced inhibition of calcium channel function (Sahara and Westbrook, 1993) . Furthermore, quisqualate, a potent group I mGluR agonist, inhibits voltage sensitive calcium channels in hippocampal neurons (Lester and Jahr, 1990) . Finally, the agonist rank order of potency for modulation of calcium channels in dissociated CA3 pyramidal cells is quisqualate > glutamate > ibotenate > truns-ACPD, and this group reported that L-AP4 was not effective at inhibition voltage-gated calcium channels in these cells (Swartz and Bean, 1992) . This rank order of potency is consistent with mediation by a group I mGluR, but not by a group II or group III mGluR (see Pin and Duvoisin, 1995) . Thus, it is possible that group I mGluRs reduce synaptic transmission by inhibiting voltage-sensitive calcium channels. The present finding that DHPG has no effect on either frequency or amplitude of mEPSCs is consistent with this hypothesis. If DHPG is acting through this mechanism, one may not expect to observe a modulation of mEPSC frequency. Indeed, the present and previous studies have shown that blockade of voltage-sensitive calcium channels with cadmium, nifedipine, nimodipine or o-conotoxin do not decrease the basal frequency of mEPSCs in CA1 pyramidal cells (see Fig.  7 and Parfitt and Madison, 1993) , but calcium channel blockers do inhibit synaptic transmission in area CA1 ( Fig. 7 and Luebke et al., 1993; Wheeler et al., 1994) . Thus, while the exact mechanism by which DHPG decreases synaptic transmission at the Schaffer collateral-CA1 synapse is not known, our data suggest that DHPG may decrease action potential-dependent glutamate release by inhibiting voltage-sensitive calcium channel function. Future studies should directly address this possibility. The present data and previous studies suggest that L-AP4 also reduces transmission at the Schaffer collateral-CA1 synapse by a presynaptic mechanism. As with DHPG, the precise mechanism by which L-AP4 acts is not yet known. However, it is interesting to note that L-AP4 may reduce synaptic transmission at this synapse by a mechanism that is independent of voltagedependent calcium channels. For instance, only about 10% hippocampal pyramidal neurons in culture possess L-AP4-sensitive receptors that modulate calcium channels (Sahara and Westbrook, 1993) . Furthermore, as mentioned above, blockers of voltage-sensitive calcium channels do not decrease the basal frequency of mEPSCs in area CA1 (Fig. 7 and Parfitt and Madison, 1993) . The present finding that L-AP4 reduces mEPSC frequency suggests that L-AP4-sensitive receptors localized on Schaffer collateral terminals may act to decrease glutamate release by inhibiting some other component of the glutamate release process. Interestingly, we have recently performed immunocytochemistry studies in which we found that mGluR7 antibodies stained vericose and punctate fibers in the stratum radiatum of area CA1 (Bradley et al., 1995, submitted) . This is consistent with the hypothesis that mGluR7 has a largely presynaptic localization in the area of Schaffer collateral terminals. However, immunocytochemistry studies at the electron microscopy level will be required to rigorously determine the pre-and postsynaptic localization of the group III mGluRs in the hippocampal formation.
Taken together with previous studies showing that activation of group II mGluRs can regulate excitatory (Lovinger and McCool, 1995) and inhibitory (Hayashi et al., 1993; Poncer and Miles, 1994 ) synaptic transmission, the present studies suggest that mGluRs belonging to all three groups can modulate synaptic transmission. This is in contrast to the receptors for other neuromodulatory transmitters such as norepinephrine, serotonin, adenosine, and others, for which only a relatively limited subset of the receptors are believed to serve as presynaptic autoreceptors. The fact that receptors from all mGluR groups can act to depress synaptic transmission speaks to the physiological importance of this phenomenon in brain function.
We also examined the mGluR subtypes involved in modulation of GABAergic transmission in CAl. We found that the selective group I mGluR agonist, DHPG, and the potent and relatively selective group I agonist, quisqualate, both reduced monosynaptic IPSPs in area CA1 , whereas the group II-selective agonist, DCG-IV, and the group III-selective agonist, L-AP4, had no effect. The sensitivity of the mGluR that modulates GABAergic transmission in area CA1 to DHPG and quisqualate suggests that this receptor is likely a group I mGluR (mGluR1 or mGluR5). The sensitivity of this receptor to antagonism by (+)MCPG is also consistent with this hypothesis.
Although DHPG markedly reduced monosynaptic IPSPs, it had no effect on the amplitude or frequency of mIPSCs. This finding is consisitent with a presynaptic site of action. Calcium channel inhibition has been proposed as a mechamism for mGluR-mediated depression of GABAergic transmission in the striatum, based on the finding that rruns-ACPD reduced the amplitude of high voltage-activated calcium currents and depressed GABA-mediated synaptic potentials with similar potency (Stefani et al., 1994) . However, it is important to note that previous studies suggest that mGluR activation can induce large inward currents or depolarization in oriens/alveus interneurons in the hippocampus (Miles and Poncer, 1993; McBain et al., 1994) This could reduce the amplitude of evoked IPSPs by inducing a depolarization block of action potential generation. The present results cannot discriminate between inhibition of GABA release from presynaptic terminals and a depolarization block of action potential generation or propagation.
It is interesting that both DHPG and L-AP4 reduced polysynaptically evoked IPSPs in area CAl, whereas only DHPG reduced monosynaptically evoked IPSPs. Since L-AP4 does not reduce transmission at GABAergic synapses, it is likely that reduction of polysynaptic IPSPs by L-AP4 is due to reduced transmission at excitatory synapses onto inhibitory interneurons, as described by Desai et al (1994) .
In conclusion, we have provided evidence that at least two distinct mGluR subtypes, one with a group I-like pharmacology and one with a group III-like pharmacology, are involved in mGluR-mediated depression of excitatory synaptic transmission at the Schaffer collateral-CA1 synapse. Analysis of mEPSCs and paired-pulse facilitation suggests that both receptors are localized presynaptically, but that they may regulate transmission through different mechanisms. In addition, a group I-like mGluR localized on GABAergic nerve terminals may regulate inhibitory synaptic transmission in area CAl. In future studies, it will be important to determine the precise mechanisms involved in the modulation of excitatory and inhibitory synaptic transmission by group I mGluRs and the specific mGluR subtypes within groups I and III that mediate these responses.
